Niranjan Jeganathan MD
Critical Care Medicine, Interstitial Lung Diseases, Occupational & Environmental Lung Disease
Physician
Join to View Full Profile
11234 Anderson StRm 1516Loma Linda, CA 92354
Phone+1 909-558-4000
Fax+1 909-558-0429
Dr. Jeganathan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Rush University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2011 - 2014
West Suburban Medical CenterResidency, Internal Medicine, 2008 - 2011
Ross University School of MedicineClass of 2008
Certifications & Licensure
CA State Medical License 2016 - 2026
IL State Medical License 2011 - 2020
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Comparative analysis of COVID-19-related mortality risk in chronic lower respiratory disease and interstitial lung disease.George W Hafzalla, Hyein Ji, Niranjan Jeganathan
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases. 2024-12-10 - 1 citationsUrban-Rural Differences in Idiopathic Pulmonary Fibrosis-Related Mortality Rates in the United States.Niranjan Jeganathan, Matheni Sathananthan
Chest. 2024-04-01 - Interstitial Lung Disease Cases, Prevalence Rates and Trends Among States in the United States.Niranjan Jeganathan, Matheni Sathananthan
Chest. 2024-02-01
Press Mentions
Rheumatoid Arthritis-ILD Mortality Remains Stable Despite Fewer Arthritis-Related DeathsDecember 29th, 2021- IPF Mortality in US Decreased from 2004 to 2017February 1st, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
